Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Long-Term Debt Repayments (2022 - 2025)

Pulmonx (LUNG) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $1000.0 as the latest value for Q3 2025.

  • Quarterly Long-Term Debt Repayments changed N/A to $1000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $97000.0 through Sep 2025, up 7.78% year-over-year, with the annual reading at $95000.0 for FY2024, 1.06% up from the prior year.
  • Long-Term Debt Repayments for Q3 2025 was $1000.0 at Pulmonx, down from $49000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Repayments was $49000.0 in Q4 2024, with the low at $1000.0 in Q3 2025.
  • Average Long-Term Debt Repayments over 4 years is $35000.0, with a median of $45000.0 recorded in 2022.
  • The sharpest move saw Long-Term Debt Repayments rose 9.3% in 2023, then increased 4.26% in 2024.
  • Over 4 years, Long-Term Debt Repayments stood at $43000.0 in 2022, then increased by 9.3% to $47000.0 in 2023, then grew by 4.26% to $49000.0 in 2024, then plummeted by 97.96% to $1000.0 in 2025.
  • According to Business Quant data, Long-Term Debt Repayments over the past three periods came in at $1000.0, $49000.0, and $47000.0 for Q3 2025, Q4 2024, and Q4 2023 respectively.